These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 12085365

  • 21. Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers.
    Zhai Y, Zhou G, Deng G, Xie W, Dong X, Zhang X, Yu L, Yang H, Yuan X, Zhang H, Zhi L, Yao Z, Shen Y, Qiang B, He F.
    Gastroenterology; 2006 Jun; 130(7):2001-9. PubMed ID: 16762623
    [Abstract] [Full Text] [Related]

  • 22. [p53 gene codon 72 polymorphism and genetic susceptibility to hepatocellular carcinoma in Chinese population].
    Zhu ZZ, Cong WM, Liu SF, Dong H, Zhu GS, Wu MC.
    Zhonghua Yi Xue Za Zhi; 2005 Jan 12; 85(2):76-9. PubMed ID: 15774209
    [Abstract] [Full Text] [Related]

  • 23. Liver intestine-cadherin (CDH17) haplotype is associated with increased risk of hepatocellular carcinoma.
    Wang XQ, Luk JM, Garcia-Barcelo M, Miao X, Leung PP, Ho DW, Cheung ST, Lam BY, Cheung CK, Wong AS, Lau SS, So MT, Yu WC, Cai Q, Liu KS, Hui CK, Lau GK, Poon RT, Wong J, Fan ST.
    Clin Cancer Res; 2006 Sep 01; 12(17):5248-52. PubMed ID: 16951245
    [Abstract] [Full Text] [Related]

  • 24. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
    Chuma M, Hige S, Nakanishi M, Ogawa K, Natsuizaka M, Yamamoto Y, Asaka M.
    J Gastroenterol Hepatol; 2008 Sep 01; 23(9):1431-6. PubMed ID: 18854000
    [Abstract] [Full Text] [Related]

  • 25. Genetic polymorphisms of glutathione-S-transferase and microsomal epoxide hydrolase in egyptian acquired aplastic anemia patients.
    Youssry I, Hammoud R, Ibrahim O, Youssef M, Beshlawy A.
    J Pediatr Hematol Oncol; 2011 Mar 01; 33(2):89-92. PubMed ID: 21228718
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. High TT virus load as an independent factor associated with the occurrence of hepatocellular carcinoma among patients with hepatitis C virus-related chronic liver disease.
    Tokita H, Murai S, Kamitsukasa H, Yagura M, Harada H, Takahashi M, Okamoto H.
    J Med Virol; 2002 Aug 01; 67(4):501-9. PubMed ID: 12115995
    [Abstract] [Full Text] [Related]

  • 28. Combined analysis of polymorphisms in glutathione S-transferase M1 and microsomal epoxide hydrolase in lung cancer patients.
    Habalová V, Salagovic J, Kalina I, Stubna J.
    Neoplasma; 2004 Aug 01; 51(5):352-7. PubMed ID: 15640939
    [Abstract] [Full Text] [Related]

  • 29. CD81 nucleotide mutation in hepatocellular carcinoma and lack of CD81 polymorphism in patients at stages of hepatitis C virus infection.
    Itakura J, Nagayama K, Enomoto N, Sakamoto N, Tazawa J, Izumi N, Marumo F, Sato C.
    J Med Virol; 2001 Jan 01; 63(1):22-8. PubMed ID: 11130883
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Association of TP53 gene polymorphisms with genetic susceptibility to liver metastases of colorectal cancer].
    Wang AZ, Zhu ZZ, Cong WM.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr 01; 25(2):168-71. PubMed ID: 18393238
    [Abstract] [Full Text] [Related]

  • 32. Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: genes involved in tumor progression.
    Mas VR, Maluf DG, Stravitz R, Dumur CI, Clark B, Rodgers C, Ferreira-Gonzalez A, Fisher RA.
    Liver Transpl; 2004 May 01; 10(5):607-20. PubMed ID: 15108252
    [Abstract] [Full Text] [Related]

  • 33. Interleukin-10 - 1082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection.
    Persico M, Capasso M, Persico E, Masarone M, Renzo Ad, Spano D, Bruno S, Iolascon A.
    J Hepatol; 2006 Dec 01; 45(6):779-85. PubMed ID: 17049666
    [Abstract] [Full Text] [Related]

  • 34. Association between allelic polymorphisms of metabolizing enzymes (CYP 1A1, CYP 1A2, CYP 2E1, mEH) and occurrence of colorectal cancer in Hungary.
    Kiss I, Orsós Z, Gombos K, Bogner B, Csejtei A, Tibold A, Varga Z, Pázsit E, Magda I, Zölyomi A, Ember I.
    Anticancer Res; 2007 Dec 01; 27(4C):2931-7. PubMed ID: 17695473
    [Abstract] [Full Text] [Related]

  • 35. A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection.
    Zhu ZZ, Cong WM, Liu SF, Xian ZH, Wu WQ, Wu MC, Gao B, Hou LF, Zhu GS.
    Cancer Lett; 2005 Nov 08; 229(1):77-83. PubMed ID: 15979781
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
    Pekow JR, Bhan AK, Zheng H, Chung RT.
    Cancer; 2007 Jun 15; 109(12):2490-6. PubMed ID: 17487861
    [Abstract] [Full Text] [Related]

  • 39. [Relationship of genetic polymorphism of microsomal epoxide hydrolase with susceptibility of chronic benzene poisoning].
    Zhang ZB, Gu SY, Wan JX, Jin XP, Xia ZL.
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2004 Jun 15; 22(3):176-80. PubMed ID: 15256148
    [Abstract] [Full Text] [Related]

  • 40. Polymorphism of the TLR4 gene reduces the risk of hepatitis C virus-induced hepatocellular carcinoma.
    Agúndez JA, García-Martín E, Devesa MJ, Carballo M, Martínez C, Lee-Brunner A, Fernández C, Díaz-Rubio M, Ladero JM.
    Oncology; 2012 Jun 15; 82(1):35-40. PubMed ID: 22286521
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.